Finnish diagnostics firm Mobidiag Ltd. will launch COVID-19 tests across Europe, following receipt of EU approval for its Novodiag and Amplidiag molecular assays to detect the SARS-CoV-2 virus. The tests were made available earlier this year in Finland, Sweden and France under emergency authorization approvals.
The Amplidiag COVID-19 assay, based on high-throughput PCR technology, is for use in large hospital labs, while Novodiag is a rapid, automated test targeted at smaller labs. “We think there...